MedTrace Logo

A Study of Lung Cancer Screening in People With Unexplained Weight Loss

NCT06717334 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 409

Last updated 2026-01-23

No results posted yet for this study

Summary

The researchers are doing this study to see if people with unexplained weight loss who have lung cancer screening are more likely to have or develop lung cancer than people without unexplained weight loss. The lung cancer screening will involve use of low-dose computed tomography (LDCT), a CT scan that gives off very low doses of radiation and can make detailed pictures of the lungs to help find tumors. The study researchers will also analyze participants' blood samples to determine if blood testing can be used to help to diagnose lung cancer.

Conditions

  • Lung Cancer Screening

Interventions

DIAGNOSTIC_TEST

Low Dose CT imaging

at baseline and at Year 1.

OTHER

blood draws

at baseline and at Year 1.

OTHER

screening questionnaire

at baseline and at 1 year after registration.

Sponsors & Collaborators

Principal Investigators

  • Puneeth Iyengar, MD, PhD · Memorial Sloan Kettering Cancer Center

Eligibility

Min Age
50 Years
Max Age
80 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2024-12-02
Primary Completion
2026-12-31
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06717334 on ClinicalTrials.gov